Abbott beats quarterly profit, but pulls forecast on coronavirus concerns [Reuters (UK)]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Reuters
Abbott posts 16% fall in profit, suspends 2020 forecast on coronavirus concerns - Reuters 1 Min Read (Reuters) - Abbott Laboratories Inc ( ABT.N ) posted a 16% drop in quarterly profit on Thursday partly due to a tax expense and suspended its full-year forecast citing the uncertainty caused by the coronavirus outbreak. The company’s net earnings fell to $564 million, or 31 cents per share, in the first quarter ended March 31, from $672 million, or 38 cents per share, a year earlier. Net sales rose to $7.73 billion from $7.54 billion. Abbott has so far launched three coronavirus tests in the U.S., including an on-site diagnostic kit that can deliver results within minutes and heralded as a game changer by President Donald Trump. Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Sriraj Kalluvila All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. © 2020 Reuters. All Rights Reserved.
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Asia Cervical Cancer Screening Market Forecast Report 2024-2032, Featuring Profiles of Abbott Laboratories, Hologic, Becton, Siemens, Roche Diagnostics, Quest Diagnostics and Cardinal Health [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (NYSE: ABT) had its "buy" rating re-affirmed by analysts at Raymond James. They now have a $129.00 price target on the stock, up previously from $122.00.MarketBeat
- Abbott's Q3 Earnings Release Coming Up, EPD Business in Focus [Yahoo! Finance]Yahoo! Finance
- Diabetes Products To Drive Abbott's Q3 [Forbes]Forbes
- Gastrointestinal Diseases Therapeutics Market to Grow by USD 18.5 Billion from 2024-2028 Driven by Rising Disease Incidence, with AI Shaping Market Trends - Technavio [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 7/18/24 - Beat
ABT
Sec Filings
- 10/1/24 - Form 4
- 10/1/24 - Form 4
- 10/1/24 - Form 4
- ABT's page on the SEC website